Kinshasa — The Democratic Republic of Congo has begun to administer an experimental vaccine to halt the spread of the Ebola virus in Mbandaka, a major transport hub that is home to more than one million people and connected by river to several other large cities.
The illness, a particularly deadly form of haemorrhagic fever, killed more than 11,000 people in an epidemic that swept through West Africa in 2014-16. Here's our briefing:
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article